tsukiko.kurokawa@metagentx.com We are pleased to announce that our CMO Dai Ishikawa has been selected as the winner of PacBio 2023 APAC Revio HiFi Sequencing Experience Grant. This will enable us to obtain long DNA sequence information utilizing the Revio system.
Metagen Therapeutics and Juntendo University have been jointly researching under the ‘Microbiome Regeneration’ program, aiming to develop Fecal Microbiota Transplantation (FMT) treatments by decoding the DNA sequence information of bacteria found in the stools of patients and donors.
For more details, please refer to the website below:
■『PacBio 2023 APAC Revio HiFi Sequencing Experience Grant』